Retroperitoneal Sarcoma With Infected Necrosis: An Unfavourable Prognostic Factor by Spillane, Andrew J. & Thomas, J. Meirion
Sarcoma (1998) 2, 179± 181
ORIGINAL ARTICLE
Retroperitoneal sarcoma with infected necrosis: an unfavourable
prognostic factor
ANDREW J. SPILLANE & J. MEIRION THOMAS
Melanoma and Sarcoma Unit, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
Abstract
Purpose. To report the phenomenon of infected retroperitoneal sarcoma (RPS).
Method. Two case reports.
Results. Both patients died soon after laparotomy.
Discussion. Infected RPS is identi® ed as an entity not clearly documented in the literature. It should probably be added
to the list of poor prognostic factors when planning the management of patients with RPS.
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Introduction
The prognosis of patients with retroperitoneal
sarcoma (RPS) is poor, with an overall 5-year sur-
vival rate reported between 12± 40%
1± 9 with
rare exception.
10 The patients with the most favour-
able prognosis are those with low grade tumours
in which complete excision of the primary tumour is
achieved.
1,2,10,11,12 Even in this group the cumulative
probability of local relapse has been reported up
to 85% at 5 years.
1 There is a role for palliative
debulking of RPS and patients with low grade
tumours can have repeated surgery over many years
with a 5 year survival rate of 80%.
2 Major surgery
should probably be avoided in patients with concur-
rent metastases, low performance status and high
grade recurrent tumours unless essential for pallia-
tion.
We were involved in the management of two
patients with aggressive retroperitoneal sarcomas
who presented with severe pain that was unrespon-
sive or not suitable for other palliative therapy. They
were offered surgery with the hope of improving
their pain. At laparotomy palliative intracapsular
debulking was undertaken. Both these patients
had offensive necrotic tumour and culture
con® rmed contamination with enteric organisms.
Infected necrosis in large retroperitoneal or
intraperitoneal bowel related tumours is a
recognised but uncommon clinical ® nding
13
however there is only one report of infected RPS
in the literature.




This 51-year-old woman presented in January 1998
with abdominal pain and a pelvic mass. Computed
tomography (CT) Scan showed a 9 cm pelvic mass
thought to be arising from the uterus. At the laparo-
tomy by her gynaecologist a retroperitoneal mass in
the lower abdomen was biopsied and found to be a
spindle cell sarcoma. Postoperatively she had ongo-
ing pain that required daily morphine but was
apyrexial. She was referred to the Royal Marsden
Hospital and was initially advised that there was no
other palliative options. There was a considerable
increase in the size of the tumour on repeat CT
Scan (see Fig. 1). After repeated representations by
the patient and her family a further laparotomy was
agreed to. There was a large pelvic mass of necrotic
offensive tumour with adherent loops of small
bowel. This was debulked. Postoperatively she de-
veloped sepsis and respiratory failure. It was decided
not to reintubate her and she died 48 hours postop-
eratively. The bacterial culture from the necrotic
tumour grew Streptococcus milleri, coliforms and
anaerobes. Histopathology demonstrated spindle
cell sarcoma (EORTC grade 2) perhaps represent-
ing gastrointestinal stromal tumour (of autonomic
type).
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Fig. 1. Large pelvic tumour with extensive necrosis. There is an intrauterine device in the uterus.
Case 2
This 35-year-old woman was diagnosed with a
retroperitoneal biphasic synovial sarcoma (EORTC
Grade 2) in April 1997. It was incompletely resected
at that time. She received 2 cycles of ifosfamide and
doxorubicin which were poorly tolerated and thus
stopped despite a partial response. She had several
episodes of unexplained fever with the chemo-
therapy. In January 1998 she had progressive dis-
ease on CT Scan and poorly controlled abdominal
pain. Debulking surgery was the only option to
attempt to improve her quality of life. Preoperatively
she had one temperature of 39°C and was com-
menced on broad spectrum antibiotics. At laparo-
tomy the mass was debulked of large volumes of
offensive necrotic material. Microbiological culture
grew Streptococcus milleri and Bacteroides
melaninogenious. Postoperatively she made good
progress however she represented to hospital one
month after surgery with severe abdominal pain. In
the course of investigating the pain, she deteriorated
and had an hypovolaemic cardiac arrest due to
presumed intra-abdominal bleeding. She was ini-
tially resuscitated however under the circumstances
it was considered inappropriate to intervene further.
She died that evening.
Discussion
Retroperitoneal sarcomas have a poor long term
prognosis with an overall 5-year survival rate re-
ported between 12 and 40%
1± 9 with one report of
63% 5-year survival.
10 They also have an ongoing
signi® cant recurrence and mortality rate after that
time.
1,5,10,11 Even when the tumour is macroscopi-
cally removed it has been reported that there is a
cumulative probability of local relapse between 50±
80% at 5 years.
1± 10 Despite this there are many cases
of recurrent low grade sarcomas that are able to be
debulked at regular intervals with medium to long
term survival.
2,3 The factors related to poor prognosis
include metastatic disease which is often transperi-
toneal seeding,
1 failure to accomplish complete exci-
sion,
1± 3,5,6,10± 12 high grade tumours
1-3,5,9,10 and in some
series the histopathological type of tumour.
3,15± 17
The failure to accomplish complete excision is a
manifestation of the size of the tumour. This relates
to and is in¯ uenced by its location in relationship
to vital structures and the number of organs in-
volved.
1,2,4,5 To the list of poor prognostic features
we would add infected RPS. The ® nding of
infected necrosis in advanced abdominal and
retroperitoneal tumours is a recognised but an un-
common clinical ® nding having been described in
lymphoma, renal cell carcinoma and metastatic
testicular carcinoma,
13 however, there is only one
report of infected RPS involving a duodenal
leiomyosarcoma.
14 There are no previous reports
suggesting a relationship to prognosis and risks of
reoperation for palliation. From our experience, if
identi® ed preoperatively infected RPS would deter
further palliative surgery in favour of persisting
with conservative therapy including appropriate anti-
biotics.
In both of our cases the nature of the aggressive
disease was such that bowel was intimately involved
and thus the presumed portal of entry of the infec-
tion. The bacteria cultured are known gut organ-
isms. The other possible portal of entry is blood
born organisms that seed the tumour but this is less
likely given both cases were polymicrobial. No
precedent exists for establishing the diagnosis of
infected retroperitoneal sarcoma however there are
similarities to infected necrosis in severe acute pan-
creatitis. Therefore CT Scan guided biopsy and
culture should be feasible.
18 Similarities to infected
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mycotic splenic artery aneurysm causing cata-
strophic bleeding and multiorgan failure from sep-
sis, also bear striking similarity to our cases.
18
In conclusion, retroperitoneal sarcomas have a
poor prognosis. Patients should only be offered pal-
liative surgery when their symptoms cannot be con-
trolled by any other modality and it is technically
feasible to reduce the bulk of their disease. If in-
fected necrosis is suspected clinically CT guided
aspiration for microbiological culture could be used
for diagnosis. Based on our recent experience in-
fected RPS may deter further palliative surgery in
favour of conservative management. Any RPS found
to have necrosis at surgery should be sent for micro-
biological culture as well as histopathology.
References
1 Alvarenga J-C, Ball ABS, Fisher C, Fryatt I, Thomas
JM. Limitations of surgery in the treatment of
retroperitoneal sarcoma. Br J Surg 1991; 78; 912± 16.
2 Jenkins MP, Alvaranga JC, Thomas JM. The manage-
ment of retroperitoneal soft tissue sarcomas. Eur J
Cancer 1996; 32A; 4; 622± 26.
3 Cody HS, Turnbull AD, Fortner JG, Hadju SI. The
continuing challenge of retroperitoneal sarcomas.
Cancer 1981; 47; 2147± 52.
4 Adam YG, Oland J, Halevy A, Reif R. Primary
retroperitoneal soft-tissue sarcoma. J Surg Oncol 1984;
25; 8± 11.
5 McGrath PC, Neifeld JP, Lawrence W et al., Im-
proved survival following complete excision of
retroperitoneal sarcomas. Ann Surg 1984; 200; 200±
204.
6 Karakousis CP, Velez AF, Emrich U. Management of
retroperitoneal sarcomas and patient survival. Am J
Surg 1985; 150; 376± 380.
7 Salvadori B, Cusumano F, delle Donne V, de Lellis R,
Conti R. Surgical treatment of 43 retroperitoneal sar-
comas. Eur J Surg Oncol 1986; 12; 29± 33.
8 Solla LA, Reed K. Primary retroperitoneal sarcomas.
Am J Surg 1986; 152; 496± 98.
9 Dalton RR, Donohue JH, Mucha P, van Heerden JA,
Reiman HM, Chen S. Management of retroperitoneal
sarcomas. Surgery 1989; 106; 725± 33.
10 Karakousis CP, Gerstenbluth R, Kontzoglou K,
Driscoll D. Retroperitoneal sarcomas and their man-
agement. Arch Surg 1995; 130; 1104± 1109.
11 Heslin MJ, Lewis JJ, Nadler E, Newman E, Woodruff
JM, Casper ES, Leung D, Brennan MF. Prognostic
factors associated with long-term survival for
retroperitoneal sarcoma: implications for manage-
ment. J Clin Oncol 1997; 15; 8; 2832± 39.
12 Singer S, Corson JM, Demetri GD, Healey EA, Mar-
cus K, Eberlein TJ. Prognostic factors predictive of
survival for truncal and retroperitoneal soft-tissue sar-
coma. Ann Surg 1995; 221; 12; 185± 95.
13 Kastroff KIM, Turnbull AD, Rotstein LE, Raaf JIH.
Doudeno-jejunostomy and stapled occlusion for distal
duodenal perforation from malignant retroperitoneal
tumours. J Surg Oncol 1984; 26; 252± 55.
14 Pitcher M, Colfor A, Moskovic B, Thomas JIM.
Duodenal leimyosarcoma as a cause of retro-
peritoneal sepsis. Eur J Surg Oncol 1995; 21; 1; 85± 86.
15 Pack GT, Tabah EJ. Primary retroperitoneal tumours:
a study of 120 cases. Surg Gynecol Obstet 1954;
99; 209± 231, 313± 41.
16 Jacobsen S, Juul-Jorgensen S. Primary retroperitoneal
tumours. Acta Chir Scand 1974; 140; 498± 500.
17 Stower MJ, Hardcastle ID. Malignant retroperitoneal
sarcoma; a review of 32 cases. Clin Oncol 1982;
8; 257± 63.
18 Rattner DW, Warshaw AL. Acute panreatitis. In:
Morris PJ and Malt RA, eds Oxford Textbook of
Surgery. Oxford: Oxford University Press,
1994; 1289± 98.